Podcasts about chief scientific

On this episode of The Vitamin Professor Podcast, Professor Gene Bruno talks to Fred Monsuur about the benefits that silicium has for skin, joint and bone health.Based in Belgium, Fred Monsuur is the Chief Scientific and Development Officer atSil'Innov and Eytelia where he brings innovation and protection into the field ofmesoporous silica formulation developments . He is also the Director of ConSilation, aconsultancy focused on Silica Based Innovations and the use of mesoporous silica infood, nutra, pharma, and more.Fred has over 25 years of experience in the field including research, patent filing, newbusiness development, technical sales, and product development and launch. Hebelieves in the power of innovation, out of the box thinking, and problem solving topropel human health forward.Fred holds degrees in medicinal chemistry and pharmaceutical technology and has apassion for people, classic cars, music and mesoporous silica.This podcast is brought to you in partnership with VRM Media and Nutraland USA, Inc.For more information about our host and guest, please see the below information.silinnov.euhttps://www.linkedin.com/in/fred-monsuur-saved-son-brother-husband-proudfather-brokenhartforhomelesschildren-mesoporoussilica/nutralandusa.comlinkedin.com/in/gene-bruno-ms-mhs-rh-ahg-2ab0508/www.vrmmedia.com@hnvirtual, #hnvirtual, #fredmonsuur, #genebruno, #thevitaminprofessorFind our podcast on your favorite platform:podcasts.apple.com/us/podcast/the-vitamin-professor-podcast/id1746137375youtube.com/channel/UCxeQ-IuqCRmq0YLc7jQNMKAmusic.amazon.com/podcasts/a8a96593-b93c-48cf-9fe9-2891c4035dad/the-vitamin-professor-podcastiheart.com/podcast/269-the-vitamin-professor-podc-175888136/

Today's guests are Anna Berkenblit, Chief Scientific and Medical Officer at the Pancreatic Cancer Action Network, and Sudheer Doss, Chief Business Officer at PanCAN. The Pancreatic Cancer Action Network is the leading organization dedicated to advancing progress against pancreatic cancer. It empowers patients and caregivers, drives early detection strategies, and revolutionizes the development of advanced and personalized treatments.TPM E45 highlights >⁠⁠⁠⁠⁠⁠⁠⁠Episode 45 links:Anna Berkenblit on LinkedInSudheer Doss on LinkedInPanCANFor access to data through PanCAN's SPARK platform, please visit: PanCAN.org/sparkFor more information, contact PanCAN Patient Services with questions about any type of pancreatic cancer – we are here to help.

Leaders and decision makers in government, industry and education have convened at Hillsborough Castle for a landmark gathering set to shape Northern Ireland's strategic approach to artificial intelligence implementation, adoption, and governance for the next decade. Hosted by the Artificial Intelligence Collaboration Centre (AICC), the inaugural AI Castle Conversation was addressed by Head of the Northern Ireland Civil Service Jayne Brady MBE, Chief Scientific and Technology Adviser Professor Helen McCarthy, Department for the Economy Permanent Secretary Ian Snowden and Ulster University Vice Chancellor Professor Paul Bartholomew. In a defining moment for AI policy and adoption in Northern Ireland, the deep dialogue event serves as a critical precursor to the formation of a new AI Taskforce under The Executive Office and forthcoming Office of AI and Digital, announced in the recent Northern Ireland Programme for Government. David Crozier CBE, AICC Director, said: "The conversations held this week will directly inform strategic priorities and policy developments, not least the creation of a comprehensive AI Action Plan for Northern Ireland. The Prime Minister has recently outlined his national vision for AI implementation, stating that no person should spend time on a task where digital or AI can do it better, quicker, and to the same high quality and standard. While work is required to address the complex implications of the technology, our ambition for Northern Ireland aligns directly. "This region is uniquely positioned, with our strong academic institutions, growing technology sector and cross-border collaboration opportunities to harness the transformative potential of AI. By convening senior officials to establish a shared vision and coordinated approach to AI adoption and governance, the AI Castle Conversation will be instrumental in shaping Northern Ireland's AI journey." Sponsored by Accenture, Analytics Engines, AWS, Deloitte, Microsoft and Version 1, the AI Castle Conversation is the first of six 'Deep Dialogues' due to take place at the historic royal palace. Hillsborough Castle has, throughout history, played host to countless discussions and negotiations aimed at fostering understanding and peace. This facilitation of dialogues that shape and advance societal issues on the island of Ireland, in a place that inspires worlds and minds to meet, continued with the inaugural AI Castle Conversation. Aligning with the five key sub-groups of the AI Taskforce, the event examined AI governance, infrastructure, data, skills and public sector transformation. With each session structured to understand where we are now, where we need to get to with clear targets and objectives, and how we get there via a practical roadmap for implementation. The AI summit at Hillsborough Castle was a series of focused discussions covering the following: · AI Tech: Donnacha Kirk, Deputy Director of AI Technology & Research Services, AICC. · AI Ethics, Governance and Responsibility: Tadhg Hickey, Head of AI & Digital Ethics Policy, AICC. · AI Skills: Michaela Black, Professor of Artificial Intelligence, Ulster University. · Real-world use cases for Public Sector Transformation through AI. · Live interactive roundtable engagement on areas to inform the AI Strategy. · Fireside chat with Thom Kenney, Fellow, Harvard Kennedy School, Harvard University, hosted by journalist and presenter Jim Fitzpatrick. In a modern take on conferencing, an instant, comprehensive report was developed in real-time during the engagement and distributed to all participants to provide public sector officials with a summary of actions for the implementation of an AI strategy for Northern Ireland. The AICC, an Ulster University-led initiative in partnership with Queen's University Belfast, was established in March 2024 as part of a £16.3 million investment by Invest Northern Ireland and the Department for the Economy. Their mission is to advance awareness and adoption o...

The First Lady of Nutrition welcomes Dr. Wolfgang Brysch, co-founder and Chief Scientific and Medical Advisor of IU Labs. He is the co-inventor of 26 patents focused on healthy aging, inflammation, and performance optimization. In this intriguing episode, Dr. Brysch tells the story of a promising new drug developed after the discovery of a groundbreaking molecule for Muscular Dystrophy in children. When faced with long approval timelines, Dr. Brysch turned to natural compounds—with results that exceeded expectations. In addition, Ann Louise and Dr. Brysch discuss muscle loss, sarcopenia, aging, and Parkinson's, shedding light on how oxidative stress damages dopamine-producing neurons and how natural compounds may offer new hope. Plus, Dr. Brysch shares insights on Long COVID, vaccine effects, and cutting-edge wellness trends like methylene blue. Don't miss this eye-opening discussion on the future of natural health! Learn more at https://iulabs.co/. The post Breakthroughs in Aging, Muscular Dystrophy, and Natural Health – Episode 189: Dr. Wolfgang Brysch first appeared on Ann Louise Gittleman, PhD, CNS.

Hosts Gregg Masters and Fred Goldstein welcome Dr. Anne Snowdon, a trailblazer in digital health and a professor at an Ontario business school. With her extensive experience as a nurse, academic, and researcher, Dr. Snowdon shares her insights into the state of digital health, the challenges of patient engagement, the promise of predictive tools, and the critical need for building smarter, connected communities. Tune in for an enlightening discussion that bridges gaps between technology, care delivery, and equity, as we explore what it takes to truly transform healthcare systems. To stream our Station live 24/7 visit www.HealthcareNOWRadio.com or ask your Smart Device to “….Play Healthcare NOW Radio”. Find all of our network podcasts on your favorite podcast platforms and be sure to subscribe and like us. Learn more at www.healthcarenowradio.com/listen

Elisabeth Roider is Harvard-and Swiss-trained, internationally renowned physician scientist. As a Partner & Chief Scientific and Medical Officer at Maximon is she dedicated to bring the field of longevity to the next level. As a physician-scientist, she works at the University Hospital of Basel and the Harvard Medical School. Her multidisciplinary team includes clinicians and clinical trial specialists, biologists, chemists, machine learning specialists, mathematicians, statisticians, and epidemiologists, allowing a bench-to-bedside approach to solve complex, medical questions in the most efficient way. Her work has resulted in various high-impact publications, patents and awards. Driven by the mission to identify and solve the most relevant medical and public health problems, Elisabeth most recently joined Maximon as a Partner Chief Scientific and Medical Officer. Here she aims to support scientists and physicians in transforming true innovation into solid solutions and products, helping patients and consumers to achieve a better, healthier and finally longer life. Chapters 00:00 Introduction to Longevity and the Guest's Background 02:49 The Intersection of Medicine, Science, and Business in Longevity 05:57 Innovative Senior Living Concepts and Mental Health 08:48 The Evolving Longevity Industry and Its Mainstream Acceptance 11:55 Economic Implications of Longevity and Preventative Medicine 14:50 Challenges in Healthcare Systems and Chronic Disease Management 17:59 The Role of GLP-1 Agonists and Other Treatments in Longevity 20:48 Practical Longevity Strategies and Personal Health Optimization 24:00 Testing and Monitoring for Longevity 26:56 Conclusion and Future Directions in Longevity Research

In this episode, Ayesha spoke with Steffen-Sebastian Bolz, MD, PhD, a scientist, physician and entrepreneur. He is a Co-Founder of Aphaia Pharma AG and Founder and Chief Scientific and Medical Officer at Qanatpharma AG. Dr. Bolz holds a full professorship at the University of Toronto, is a Principal Investigator at the Ted Rogers Centre for Heart Research and Director of the Toronto Centre for Microvascular Medicine. Aphaia Pharma is developing innovative, non-hormonal treatments for metabolic conditions like diabetes and obesity. The company is focused on restoring a normal metabolic food response through natural and safe treatment alternatives that can be applied to broad populations and enable long-term use. To learn more about Aphaia's innovative approach to treating metabolic conditions like obesity by turning to the body's natural physiology, tune into the episode with Dr. Bolz. For more life science and medical device content, visit the Xtalks Vitals homepage. https://xtalks.com/vitals/ Follow Us on Social Media Twitter: https://twitter.com/Xtalks Instagram: https://www.instagram.com/xtalks/ Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured

It's In the News! A look at the top diabetes stories and headlines happening now. Top stories this week: A new study looks at insulin needs in men vs women, updates on stem cell transplants and a new look at COVID 19 and T1D plus a fully implantable CGM is announced. We'll also tell you about a T1D athlete drafted to the MLB. Lots more in this week's episode, full transcipt below.  Find out more about Moms' Night Out  Please visit our Sponsors & Partners - they help make the show possible! Learn more about Gvoke Glucagon Gvoke HypoPen® (glucagon injection): Glucagon Injection For Very Low Blood Sugar (gvokeglucagon.com) Omnipod - Simplify Life Learn about Dexcom  Edgepark Medical Supplies Check out VIVI Cap to protect your insulin from extreme temperatures Learn more about AG1 from Athletic Greens  Drive research that matters through the T1D Exchange The best way to keep up with Stacey and the show is by signing up for our weekly newsletter: Sign up for our newsletter here Here's where to find us: Facebook (Group) Facebook (Page) Instagram Twitter Check out Stacey's books! Learn more about everything at our home page www.diabetes-connections.com  Reach out with questions or comments: info@diabetes-connections.com Episode transcription with links:   Hello and welcome to Diabetes Connections In the News! I'm Stacey Simms and every other Friday I bring you a short episode with the top diabetes stories and headlines happening now. XX In the news is brought to you by Edgepark simplify your diabetes journey with Edgepark XX Do men and women have different insulin requirements? A new study conducted across Europe says yes – women overall need less. Published in the Journal of Diabetes Science and Technology this looked at over 9,000 adults with type 1 diabetes using data from patients using the Diabeloop Generation 1 (DBLG1) hybrid closed-loop pump system. In this study, women needed 14-percent less insulin overall than men. These researchers say these findings have important implications for the practical management of insulin therapy and highlight the necessity of considering gender as a crucial factor in diabetes treatment. The treatment guidelines provided by American and European Diabetes Societies do not currently have gender-specific recommendations for insulin-weight ratios. The co-founder and Chief Scientific and Technical Officer for Diabeloop. “This study also highlights the capacity to discover new insights from big-data analysis of real-world data.” *Insulin Requirements According to Gender and Weight in a Population of 9036 Adult Persons With Type 1 Diabetes Using Closed-Loop Insulin Delivery, https://doi.org/10.1177/19322968241252366). https://www.theglobeandmail.com/investing/markets/markets-news/GetNews/27419187/diabeloop-study-reveals-significative-gender-differences-in-insulin-requirements-for-type-1-diabetes-patients/   XX New drug therapy in those lucky diabetic mice boosted insulin-producing cells by 700% over three months, effectively reversing the disease. Scientists at Mount Sinai and City of Hope have been able to grow new beta cells in the body, in a matter of months. The therapy involved a combination of two drugs: one is harmine, a natural molecule found in certain plants, which works to inhibit an enzyme called DYRK1A found in beta cells. The second is a GLP1 receptor agonist. The latter is a class of diabetes drug that includes Ozempic, The researchers tested the therapy in mouse models of type 1 and 2 diabetes.. The signs of the disease quickly reversed, and stayed that way even a month after stopping the treatment.   The results are intriguing, but of course being an animal study means there's still much more work to be done before it could find clinical use. So far, harmine alone has recently undergone a phase 1 clinical trial in humans to test its safety and tolerability, while other DYRK1A inhibitors are planned for trials in humans next year. https://newatlas.com/medical/diabetes-reversing-drug-boosts-insulin-producing-cells/ XX Stem cell–derived beta-cell replacement therapy continues to show benefit in people with type 1 diabetes at a high risk for severe hypoglycemia. New info from Vertex shows that of a total 17 patients who received a full dose of their  investigational allogeneic stem cell–derived, fully differentiated pancreatic islet cell replacement therapy (VX-880), three, thus far, have achieved the primary study efficacy endpoint of elimination of severe hypoglycemic episodes with A1c < 7% at 1 year and the secondary endpoint of insulin independence. Others are on the same trajectory, Piotr Witkowski, MD, PhD, professor of surgery at The University of Chicago, Chicago, said at the recent American Diabetes Association (ADA) 84th Scientific Sessions. In his presentation, Witkowski also provided details about the deaths of two study participants that the company had announced in January 2024, neither of which were related to the VX-880 product. In fact, there have been no severe adverse events related to the product itself, with most due to either the infusion procedure or the immunosuppression. "These data highlight the curative potential of VX-880 in people living with type 1 diabetes and support further evaluation of VX-880 toward pivotal development," Witkowski said. For now, patients selected for the study are those who experience frequent severe hypoglycemia deemed to be a greater risk to the patient than that of immunosuppression. However, Ahn pointed out, "With VX-880, the obvious fly in the ointment is the need for immunosuppression which carries significant risk…There are multiple solutions being proposed, but we are still waiting for data as promising as the initial Vertex data is on that front." https://www.medscape.com/viewarticle/stem-cell-derived-islets-continue-show-benefit-t1d-2024a1000cx1 XX Still lots of COVID studies coming in about type 1. A German study suggests COVID 19 may speed up progression of existing but presymptomatic T1D in kids. These researchers had been screening and following children in an early presymptomatic stage of type 1 diabetes for several years. They noticed an increase in the numbers of Incidence of clinical type 1 diabetes nearly doubled after the pandemic started. "We know that the virus can infect the pancreatic islets so it could be causing damage or change in the beta cells that make insulin," said Ziegler when discussing possible mechanisms behind this association. "Second, there is generalized inflammation during the infection and there may be a stimulation of the immune response. Third, there could be metabolic stress from the infection that affects the beta cells that make insulin. To dive into this topic, youth were identified in the German Fr1da-screening program from 2015 to 2023. All patients had presymptomatic diabetes defined as persistent, confirmed positive results for two or more islet autoantibodies. Their progression was monitored at 3- to 6-month intervals. Clinical type 1 diabetes was defined according to American Diabetes Association   COVID infection was either self-reported via the family or identified with SARS-CoV-2 antibodies were confirmed in blood samples collected at study visits.   Vaccination against COVID-19 may be one way to protect presymptomatic type 1 diabetes youth from progression, Ziegler added. She said her group is currently testing whether COVID-19 vaccination can reduce new-onset, presymptomatic type 1 diabetes in a clinical trial  of children with genetic risk factors for the condition. https://www.medpagetoday.com/endocrinology/type1diabetes/111084 XX The FDA says no – for now - to Novo Nordisk's weekly insulin.  This has been approved in Canada and should be available there shortly. But the FDA says it wants more information related to the manufacturing process and the type 1 diabetes indication to complete the review. Novo said it does not expect to be able to fulfil the requests this year, and that it will work closely with the FDA regarding the next steps. The regulator's decision follows its outside panel's vote against the use of the weekly insulin icodec, in patients with type 1 diabetes due to risks of low blood sugar. https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-declines-approve-novo-nordisks-weekly-insulin-2024-07-10/ XX A couple of weeks ago we spoke to the attorneys taking on CGM monitronig in schools. They've helped a family in Connecticut and set a precdent.  A child with autism and diabetes was not getting reasonable accommodations under the federal Americans with Disabilities Act in a public preschool program. I'll link up the press release from the DOJ but this family wasn't getting any support and it just wasn't safe. The lawyers here tell me the ruling and settlement is just going to help them going forward as they try to make schools complient with CGM as a reasonable  accomodatin. https://www.justice.gov/usao-ct/pr/aba-therapy-provider-make-changes-comply-americans-disabilities-act   XX Ozempic could lower the risk of dementia and a range of other mental problems compared with other existing treatments for patients with diabetes. What's more, researchers found that Ozempic cut nicotine dependence in those patients.   This study relied on medical records from more than 100,000 U.S. diabetes patients, including more than 20,000 who were prescribed semaglutide between December 2017 and May 2021. After a year, patients who took Ozempic had a 48% lower risk of developing dementia than those on Januvia. The risk in Ozempic patients was also 37% lower than those who took Glucotrol and 9% lower than those on Jardiance. Notably, previous research has determined that diabetes patients are at a greater risk of developing dementia. But the authors emphasized that the analysis is observational. The results need to be replicated in a controlled trial that assigns patients to randomly take Ozempic and the other drugs, according to Dr. Max Taquet, another Oxford clinical lecturer and senior study author. https://www.cnbc.com/2024/07/16/healthy-returns-ozempic-may-lower-dementia-risk-nicotine-use.html XX   Edgepark Commercial XX The Omnipod 5 with Dexcom G7 integration is now available through select pharmacies with full availability expected in the fall.   The System uses new Pods that are compatible with both Dexcom G6 and G7, but the prescription code will stay the same as the current Omnipod 5 Pods. This means the community will have similar insurance coverage and access to what they have with Omnipod 5 today.   If you're looking to start on Omnipod 5 and you're currently using Dexcom G7, your doctor will need to send a prescription for both the Omnipod 5 Intro Kit and Omnipod 5 Pods, compatible with Dexcom G6-G7, to ASPN Pharmacies.   You can learn more at https://www.omnipod.com/innovation/dexcom-g7.   If you are already using Omnipod 5, you will get the new Pods compatible with Dexcom G6 and G7 through your Pod refills. You do not need a new prescription. The week of July 29th, you will receive a free software update for the Omnipod 5 App to your Controller or compatible Android smartphone which is needed to use the System with Dexcom G7. Accept the update. We recommend you continue to use your current Omnipod 5 Pods and Dexcom G6 supplies until the new Pods compatible with Omnipod 5 with Dexcom G6-G7 are available at your preferred pharmacy.   We'll email our users when the new Pods are available in most pharmacies.   You can learn more at https://www.omnipod.com/innovation/new-compatible-devices   XX Big promises about long-term implantable blood glucose monitor from a company called Focus. They say they're partnering with Glucotrack to quote - transform how people with diabetes interact with their condition. They're not calling this a CGM – rather it's a CBGM, continuous blood glucose monitor because it will measure glucose levels in blood, not in interstital fluid like CGMs do. They company says this is a fully subdermal location, with no external wearable. In preclinical studies, the CBGM has a MARD of 4.7% at day 90. That is MUCH lower than CGMs on the market – Dexcom and Libre are in the low 8s right now. BUT.. it hasn't been fully tested in people yet. Human clinical trials are set to start later this year. https://www.drugdeliverybusiness.com/focus-collaborates-glucotrack-implantable-cbgm/ XX Big congrats to Jamie Ferrer (Chy-may Fer-rare) On Monday, Ferrer's dream was realized when the Twins selected the Florida State outfielder in the fourth round (No. 126 overall) during Day 2 of the MLB Draft. Minnesota vice president of amateur scouting Sean Johnson said the club had its eyes on Ferrer since high school. “Recently, I was in Orlando at a conference called, “Friends for Life with CWD [Children with Diabetes],” and we had an event that was a sports day. … Kids would come up to me and either them or their families would ask me how I dealt with this [or that],” Ferrer said. “And seeing their faces light up whenever I said I was diagnosed at three and I played college baseball. … You hear people tell you no and that you can't do this because you have Type 1 diabetes … So why not inspire as many people as I can?”   “I'm super proud of being a Type 1 athlete, and it's something that I'll never shy away from talking about or showing off my insulin pump because it's who I am and it's something that I've had to deal with my entire life.” https://www.mlb.com/news/jaime-ferrer-selected-no-126-overall-by-twins-in-2024-mlb-draft XX Join us again soon!

Send us a Text Message.In today's episode, VJ is joined by Dr Wolfgang Brysch, who g is the co-founder and Chief Scientific and Medical Advisor of iüLabs, to discuss vital nutrients in managing chronic fatigue and autoimmune conditions. He leads on science, product and strategy development. Wolfgang studied medicine in Goettingen, Germany and Cambridge, UK. He started his research career in basic neurobiology and cancer research at the Max-Planck Institute for Biophysical Chemistry. He then moved into the pharma and biotech industry, gaining 30 years of experience in the development of innovative drugs and nutritional supplements. Wolfgang brings a strong scientific and innovation background along with medical expertise to the company. In the last 15 years, Wolfgang has focused his R&D around healthy ageing, inflammation, and enhancing physical and mental performance.You can learn more about iüLabs and their products here. You can download your free copy of The Autoimmune RESET here.And you can access all of VJ's free resources here.If you would like to book a free initial consultation with VJ Hamilton, The Autoimmunity Nutritionist, to find out how nutritional therapy and functional medicine could improve your health, you can book an appointment here.Thanks for listening! You can join The Autoimmune Forum on Facebook or find me on Instagram @theautoimmunitynutritionist.

In this episode of the Data Malarkey podcast, your host Sam Knowles is joined by one of the world's finest data storytellers, David Spiegelhalter, the statistician and public communicator of his generation. Although he claims to have been retired for five years, the Emeritus Professor of Statistics from Cambridge University is working harder than ever.   Our conversation was recorded remotely, via the medium of Riverside.fm, on 6 March 2024.   Thanks to Joe Hickey for production support.   Podcast artwork by Shatter Media.   Voice over by Samantha Boffin.   If anyone can be said to have had “a good pandemic”, it was David. “At least I had something to do!” he quips, sharing how he quickly set up a studio at home and gave countless interviews about what the data meant and what we should do as a result.   While he believes that the Chief Scientific and Medical Officers of the U.K. National Health Service usually presented complex information simply and straightforwardly to a willing and receptive public – hungry for evidence of what they might choose to do and why – Government ministers (to the very top) and their Special Advisors (SPADs) had little clue.   Nothing gets David more irritated than wilful misuse of data, and several times during our lively discussion he vents considerable fury at peddlers of misinformation, under COVID and otherwise. We talk a lot about communicating risk (relative and absolute), particularly under uncertainty, with uncertainty the theme of David's imminent new book, The Art of Uncertainty (to be published by Penguin in September 2024).   Away from the stats lab, we learn how David applied his data-driven smarts to winning the inaugural (and to-date only) Loop World Championship; Loop is pool played on an elliptical table with only one pocket at one of the foci of the ellipse. He also took an evidence-based approach to qualifying for the second round of Winter Wipeout, recorded a dozen years and more ago in Argentina, where David adopted the persona of Professor Risk.   In addition to uncertainty, we also focus on trustworthiness. For David, those using data and statistics to communicate need to earn and constantly re-earn a reputation for being trustworthy. And just as no-one laughs at a comedian who says “I'm funny” at the start of his set, no-one trusts a person using data to communicate complex topics who says “Just trust me!”. Being seen as trustworthy is a consequence of being honest, competent, and reliable.   David introduces Sam and the audience to the skill of “pre-bunking”, and several times warns against building data-driven narratives that push emotional levers or buttons. Data storytellers should present the evidence simply and fairly and then allow the audience to draw their own conclusions. “Treat them as if they're intelligent, but also as if they don't know anything.”   EXTERNAL LINKS Cambridge University personal profile page https://www.statslab.cam.ac.uk/~david/ David on Wikipedia https://en.wikipedia.org/wiki/David_Spiegelhalter     To find out what kind of data storyteller you are, complete our data storytelling scorecard at https://data-storytelling.scoreapp.com. It takes just two minutes, and we'll send you your own personalised scorecard which tells you what kind of data storyteller you are.  

Dr. Laura Mauri, M.D., Senior Vice President, Chief Scientific, Medical, and Regulatory Officer at Medtronic, joined The WBAP Morning News. Survey results focusing on DFW residents' pursuit of longevity; the keys we may be overlooking towards achieving it, including the importance of acknowledging the role technology can play and is playing in helping us achieve longevity, and how Dallas-Fort Worth residents' responses compare to the rest of the country.See omnystudio.com/listener for privacy information.

April 22, 2024 ~ A survey of 2,200 adults shows Detroiters are strong believers that healthcare technology can help them live longer and healthier, but only 22% say they are taking advantage of healthcare technology. Guy, Lloyd, and Jamie talk with Dr. Laura Mauri, Chief Scientific, Medical, and Regulatory Officer at Medtronic, about the study, and advice for how to discuss longevity with your doctor.

In this episode, we decided to wander the streets and queues of South by Southwest 2024 to capture viewpoints from people with diverse backgrounds at what is undoubtedly the most fascinating festival for free thinkers in the world.It all started in an elevator, where I met Robert Gabbay, Chief Scientific and Medical Officer at the American Diabetes Association, PhD, and a Harvard Medical School graduate. Robert shared his belief that helping others is a fundamental part of life, pondered how the world would be a better place if everyone embraced this philosophy, and talked about his desire to be remembered for helping people.Heading out into the street, I chatted with Moody Al-Badrawi, CEO of Spare Music, about the impact of social media on the careers of independent musicians and the importance of digital distribution. Moody shares his vision for the future of music and highlights some emerging talents in Afrobeats and lo-fi.Then, in the line for the AI Happy Hour, I met Gavin Morrison, Director of Entertainment at Web Summit, a festival similar to SXSW that takes place in Lisbon and Rio de Janeiro. He told me about the festival and the importance of technology for emerging countries, and how in less developed countries ideas make the difference in changing old problems.Inside that Happy Hour, I encountered Kyle, CEO of the Skybox AI app, who is working with Apple Arcade Labs of Apple Vision on creating immersive content and visual storytelling. Diana Bailey, who also collaborates with Kyle at the company, spoke about the impact of visual immersion on mental health. Then, an enigmatic New Yorker from Pfizer, focused on data and reporting for Salesforce, shared his insights. And finally, the conversation took an unexpected turn when emoji designer Avi Stein told us about how he decided to create a religion based on intuition and gut health.En este episodio, salimos a recorrer el festival South by Southwest 2024 para conocer diversos puntos de vista, es el festival más interesante de libres pensadores del mundo. Comenzamos en un ascensor, ahí conocimos a Robert, Chief Scientific and Medical Officer at American Diabetes Association, quien me compartió su creencia de que ayudar a los demás es una parte fundamental de la vida.Salí a la calle y platiqué con Moody Al-Badrawi CEO de Spare Music, hablamos sobre el impacto de las redes sociales en la carrera de los músicos independientes y de la importancia de la distribución digital. Luego, conocí a Gavin, Director of Entertainment de Web Summit, un festival similar al SXSW que se hace en Lisboa y Río de Janeiro. Me contó sobre la importancia de la tecnología para los países emergentes y cómo las ideas hacen la diferencia para cambiar problemas. Adentro de ese Happy hour, conocí a Kyle, el CEO de la aplicación Skybox AI que está trabajando con Apple Arcade Labs de Apple Vision en la creación de contenido inmersivo y a Diana Bailey, que también colabora en la compañía. Hablamos sobre el impacto de la inmersión visual en la salud mental. Conocí a un incógnito neoyorkino de Pfizer, que trabaja enfocado en datos y reportes para Salesforce y por último hablé con un diseñador de emojis, Avi Stein, quien narró su plan para crear una religión basada en la salud intestinal. Hosted on Acast. See acast.com/privacy for more information.

Cyclic glycine proline, or cGP,  is a very small molecule, but one with a profound impact on the body and mind, such as on the ageing brain and health. Dr Jian Guan, Neuroscientist and Chief Scientific officer at The cGP Lab, New Zealand, focuses on understanding the role of IGF-1 hormone and cGP in brain health and cognitive function, and improving the ageing process overall. Read the original research: doi.org/10.3390/molecules28031021Visit the cGP website: cgpmax.com

Chief Scientific and Medical Officer for the American Diabetes Association, Dr. Bob Gabbay, joined The Huddle live at ADCES' 2023 annual meeting in August. He touched on the challenges of addressing diabetes in primary care and the value of a DCES in this area, as well as the importance of active listening, perceived value, and engaging teaching styles when working with people with diabetes. Listen to more episodes of The Huddle at adces.org/perspectives/the-huddle-podcast.Learn more about ADCES and the many benefits of membership at adces.org/join.

Patrick Cox is a premiere anti-aging science analyst with Mauldin Economics, Chief Scientific officer for The Longevity Playbook along with his good friend and colleague Dr Mike Roizen (Mike is the co-founder of The Longevity Playbook, bestselling author, and the emeritus chief wellness officer at the Cleveland Clinic) and also Patrick is a contributor to Wall Street journal, Forbes,  USA today & has also served as a consultant for national political campaigns and Fortune 500 companiesIn this conversation with JD podcast host Andrew Cox | Joint Dynamics Patrick shares an insider's perspective on the economic realities of longevity, upcoming longevity treatments, and what we can do now to increase our health span to extend our lifespan.*our show sponsor is Muvitality Medicinal Mushrooms for modern day health and wellness | Mu …Go to muvitality.com and use the code JD10 to receive a 10% discount on your purchase of Mu Functional mushrooms such as Lions Mane, Cordyceps, Chaga, Reishi, and Turkey tail functional mushroomsEnjoyHere are some useful links for this podcastThe Longevity Playbook | LinkedInThe Methuselah Effects - How the Trend Toward Longevity is …Patrick Cox - ForbesPatrick Cox's Interview with Dr. Eugene Seymour - Mauldin EconomicsThe Longevity Playbook™ by Dr. Mike RoizenRelevant episodesEpisode 58 - Project Otto, a look into the future of health care and ongoing health optimisation - https://podcasts.apple.com/hk/podcast/episode-58-project-otto-a-look-into-the-future/id1527374894?i=1000581372113JOINT DYNAMICS links:Joint Dynamics Facebook - https://www.facebook.com/JointDynamicsHongKong/Joint Dynamics Instagram -https://www.instagram.com/jointdynamics/Joint Dynamics Youtube - https://www.youtube.com/channel/UCRQZplKxZMSvtc6LxM5WckwJoint Dynamics Website - www.jointdynamics.com.hk Host - Andrew Cox - https://www.jointdynamics.com.hk/the-team/trainers/andrew-coxThe Joint Dynamics online at home exercise program - contact admin@jointdynamics.com.hk to purchase your copy Introduction (Finalized).m4v

Listen as Matt Werbach, Associate Director of Media and Communications, discusses NPF's promising research activities and efforts to change health outcomes for all with psoriasis and psoriatic arthritis with President and CEO Leah Howard, and Chief Scientific and Medical Officer Guy Eakin. Exciting times ahead as NPF moves towards a new chapter! This Psound Bytes episode is provided with support from Bristol Myers Squibb, Janssen, and UCB. 

As a statistician, Scott Brown loves data. He's been putting that love of data to good use in his current role as Chief Scientific Strategist at BRIGHT Research Partners. Scott joined this week's podcast to discuss more about BRIGHT's work as a contract research organization. He also talks about his interesting career path that ultimately led him to healthcare, shares his favorite statistical method, and much more.

Mike Tarselli, Chief Scientific & Knowledge Officer at TetraScience discusses accelerating drug development through a unified data platform and fostering a learning culture on the AWS Health Innovation Podcast.

Synopsis: We recorded this episode in December 2022 with Florian Brand and Srinivas Rao, the Co-Founders and CEO & CSO, respectively, of atai Life Sciences, a biopharmaceutical company that leverages a decentralized platform approach to incubate and accelerate the development of highly effective mental health treatments that address the unmet needs of patients, including psychedelics and digital therapeutics. Florian and Srinivas provide an overview of the neuropsychiatry landscape, the history of psychedelics within mental health, and the role COVID played in increasing mental health awareness. They also discuss the model at atai around drug development and how they approach tackling such a massive unmet need. Finally, Florian talks about how self-awareness can lead to healthier habits and decision-making, and the importance of investing in therapy. Biography: Florian Brand is the co-founder and Chief Executive Officer of atai Life Sciences. Prior to joining atai, Florian was starting and building user-centric technology companies as a serial entrepreneur. Florian suffered from anxiety in his youth and was able to achieve remission through a combination of psychotherapy and robust meditation practice. It was ultimately his experiences seeing his friends and loved ones failed by the mental healthcare system that inspired him to join the movement to transform the treatment landscape for patients who have been unable to find relief in currently available therapies. In 2022, Florian was recognized in Fortune's 40 Under 40 list spotlighting influential individuals shaping business and Business Insider's 30 Under 40 in Healthcare. Florian was also featured in Endpoint News' list of 20 Under 40 Innovators in Biotech in 2021. He is a proud member of the Founders Pledge, a global community of mission-aligned entrepreneurs dedicated to doing good. Srinivas Rao is the Chief Scientific Officer at atai Life Sciences. Dr. Rao has over 19 years of professional experience in the pharmaceutical and biotechnology industries. Prior to atai, Dr. Rao has held the titles of Chief Scientific, Medical, or Executive Officer at companies ranging from venture-backed startups to vertically-integrated, publicly-traded pharmaceutical companies. Dr. Rao completed an internship in Internal Medicine at Yale-New Haven Hospital. He received his Ph.D. in neurobiology from Yale Graduate School and his M.D. from Yale School of Medicine. He holds both a Bachelor of Science and Master of Science degree in Electrical Engineering from Yale College and Yale Graduate School, respectively.

Here we are, my fellow health enthusiasts. Today, we're talking nature's best medicine, the science and secrets of colloidal silver – revealed! I recorded this one out in Salt Lake City, Utah at the Silver Biotics headquarters with Steve Revelli, their Chief Scientific officer. Steve's an expert on silver technology who has spent decades of his career working with and advancing silver science. This is a topic I've wanted to cover for years as silver has been part of my healing arsenal for a couple decades. But I had to find the right person for the job, and Steve delivered big time. If by the end of this episode, you want to get into the silver game yourself, here's what you do. Go to lukestorey.com/silverbiotics, and for your first time purchase, use the code LUKE30 for a whopping 30% off after your first. And after your first purchase, you can use the code LUKE for 10% off. This incredible metal just has so many useful applications. But as you'll soon learn, not all silver products are created equal. So this one's going to bust many myths and set us all straight. DISCLAIMER: This podcast is presented for educational and exploratory purposes only. Published content is not intended to be used for diagnosing or treating any illness. Those responsible for this show disclaim responsibility for any possible adverse effects from the use of information presented by Luke or his guests. Please consult with your healthcare provider before using any products referenced. This podcast may contain paid endorsements for products or services. 00:04:10 — Getting to Know Steve Revelli Background in education  Healing a wounded alley cat  Rich history of silver use around the world “Born with a silver spoon” 00:10:00 — Learning About Silver Treating burns with silver  What is colloidal silver? Colloid vs. ions  Bioactive silver hydrosol Ideal parts-per-million Battling with Big Pharma Deep dive on Silver Biotics science  Issues building up in the body Keeping your gut bacteria alive  00:34:56 — The Healing Power of Silver How does silver work in the body? Prioritizing ongoing research  How it kills pathogens  Silver and your immune system  Off-label uses of silver products Working with FDA clearance  Kills mold and fungus  Formulating silver toothpaste  Visit lukestorey.com/silverbiotics Use the code LUKE30 for 30% off Treating psoriasis and eczema Formulating products for pets  Plastic vs. glass packaging  More about this episode. Watch on YouTube. THIS SHOW IS BROUGHT TO YOU BY: SLEEPME. Science tells us that the best way to achieve and maintain consistent, deep sleep is by lowering core body temperature. Life Stylist listeners can save on the purchase of any new Cube, OOLER, or Dock Pro Sleep System, and start aiding their sleep routines today. Head to Sleep.me/LukeStorey for 25% off. AND... TIMELINE NUTRITION. Mitopure is a breakthrough postbiotic that activates your body's natural defense against aging. Clinically proven to unlock the potent bioactive, Urolithin A. It is the purest form of Urolithin A, a molecule, which is only produced as a by-product when gut bacteria digest specific ingredients found in pomegranates. Go to “LUKE10” for 10% of any 2, 4 or 12-month Mitopure plans at timelinenutrition.com. AND… SUPER SPECIOSA. Kratom is an all-natural herb related to coffee plant that has been used in Thailand for centuries. It helps energize your mind & relax your body, and just makes you feel good. Try kratom and get 20% off your entire order. Go to GetSuperLeaf.com/LUKE and use promo code LUKE for 20% off your entire order. AND… MAGNESIUM BREAKTHROUGH. According to the American Psychological Association, chronic stress is linked to the six leading causes of death. When most people think of stress, they think of their job, traffic, tense relationships, current events, things like that. But the root of so much of the stress we experience comes down to a deficiency in one overlooked nutrient — magnesium. So, if you're ready to help your body deal with stress, instead of putting a band-aid on it after the fact, you're going to want some Magnesium Breakthrough. You can use the code “luke10” for 10% off at magbreakthrough.com/luke. Resources: Visit lukestorey.com/silverbiotics and use the code LUKE30 for 30% off. Are you ready to block harmful blue light, and look great at the same time? Check out Gilded By Luke Storey. Where fashion meets function: gildedbylukestorey.com Join me on Telegram for the uncensored content big tech won't allow me to post. It's free speech and free content: www.lukestorey.com/telegram Related: Dr. Christiane Northrup: Medical Freedom, Injection Protection + How To Save Yourself & Your Sanity #435

TAKING CONTROL OF YOUR DIABETES – THE PODCAST! ...With Expert Endocrinologists Living with T1D, Drs. Steven V. Edelman & Jeremy PettusADA Standards of Care – Dr. Robert Gabbay (ADA Chief Scientific & Medical Officer)Questions We'll Cover in This Episode:•  What are the ADA Standards of Care?•  What have been the newest changes to the treatment algorithm type 2 diabetes? What new data from clinical trials lead to these changes?•  What are the current guidelines for starting insulin and how have they changed for T2D?•  What do these guidelines provide in terms of access?•  What do these guidelines suggest for weight loss as a goal?•  What is the first question your provider should ask when evaluating you?•  What are the guidelines around pregnancy for women with type 1?•  What factors go into deciding the right insulin regimen for someone with T1D?ADA Standards of Care Resources: https://professional.diabetes.org/content-page/practice-guidelines-resources**Tune in for 2 new episodes each month! Like what you hear and want to help us grow? Please rate and review this podcast so we can reach more people living with diabetes!** ★ Support this podcast ★

Dr. Srinivas Rao, MD, Ph.D. is the Chief Scientific Officer at atai Life Sciences (https://www.atai.life/), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. With offices in New York, London and Berlin, atai's business model combines funding, technology, scientific and regulatory expertise with a focus on psychedelic therapeutic moieties, and other drugs, with differentiated safety profiles and therapeutic potential. Dr. Rao also serves as CEO of atai portfolio company, EntheogeniX (https://www.entheogenixbio.com/), a computational biophysics and artificial intelligence biotech working to design the next generation of psychedelics-inspired mental health drugs. Dr. Rao has over 19 years of professional experience in the pharmaceutical and biotechnology industries. Prior to atai, Dr. Rao has held the titles of Chief Scientific, Medical, or Executive Officer at companies ranging from venture-backed startups to vertically-integrated, publicly-traded pharmaceutical companies. Dr. Rao completed an internship in Internal Medicine at Yale-New Haven Hospital. He received his Ph.D. in neurobiology from Yale Graduate School and his M.D. from Yale School of Medicine. He holds both a Bachelor of Science and Master of Science degree in Electrical Engineering from Yale College and Yale Graduate School, respectively.

#siri #renault #apple #artificialintelligence #metaverse Dr luc Julia is a world-renowned expert in Artificial Intelligence & is the co-creator of the virtual voice assistant Siri at Apple & is currently the group chief scientific officer at the Renault Group. Dr. Luc Julia participated in the launch of Nuance Communications, today the world leader in speech recognition, and co-founded several start-ups in Silicon Valley. In 1997, with a friend, he filed the patents for what would later become Siri and in 1999 presented "The Assistant", the ancestor of the voice assistant. In 2010, he became Chief Technologist at Hewlett-Packard, then joined Apple in 2011 to lead the development teams of Siri (voice command computer application). He is recognized as the co-creator of Siri. In 2012, he was appointed Senior Vice President and CTO of Samsung Electronics. In 2019, he published his book "Artificial intelligence does not exist" with First Editions. Since 2020 Luc Julia is a member of the French Academy of Technologies. On October 2020, he was awarded the Legion d'Honneur (the highest French order of merit) by the Secretary of State for the Digital Economy, in recognition of his work that has influenced the fields of Artificial Intelligence, Human-Computer Interaction, Digital Media and other advanced technologies. https://www.linkedin.com/in/lucjulia http://lucjulia.com Watch our highest viewed videos: 1-India;s 1st Quantum Computer- https://youtu.be/ldKFbHb8nvQDR R VIJAYARAGHAVAN - PROF & PRINCIPAL INVESTIGATOR AT TIFR 2-Breakthrough in Age Reversal- -https://youtu.be/214jry8z3d4DR HAROLD KATCHER - CTO NUGENICS RESEARCH 3-Head of Artificial Intelligence-JIO - https://youtu.be/q2yR14rkmZQShailesh Kumar 4-STARTUP FROM INDIA AIMING FOR LEVEL 5 AUTONOMY - SANJEEV SHARMA CEO SWAAYATT ROBOTS -https://youtu.be/Wg7SqmIsSew 5-TRANSHUMANISM & THE FUTURE OF MANKIND - NATASHA VITA-MORE: HUMANITY PLUS -https://youtu.be/OUIJawwR4PY 6-MAN BEHIND GOOGLE QUANTUM SUPREMACY - JOHN MARTINIS -https://youtu.be/Y6ZaeNlVRsE 7-1000 KM RANGE ELECTRIC VEHICLES WITH ALUMINUM AIR FUEL BATTERIES - AKSHAY SINGHAL -https://youtu.be/cUp68Zt6yTI 8-Garima Bharadwaj Chief Strategist IoT & AI at Enlite Research -https://youtu.be/efu3zIhRxEY 9-BANKING 4.0 - BRETT KING FUTURIST, BESTSELLING AUTHOR & FOUNDER MOVEN -https://youtu.be/2bxHAai0UG0 10-E-VTOL & HYPERLOOP- FUTURE OF INDIA"S MOBILITY- SATYANARAYANA CHAKRAVARTHY -https://youtu.be/ZiK0EAelFYY 11-NON-INVASIVE BRAIN COMPUTER INTERFACE - KRISHNAN THYAGARAJAN -https://youtu.be/fFsGkyW3xc4 12-SATELLITES THE NEW MULTI-BILLION DOLLAR SPACE RACE - MAHESH MURTHY -https://youtu.be/UarOYOLUMGk Connect & Follow us at: https://in.linkedin.com/in/eddieavil https://in.linkedin.com/company/change-transform-india https://www.facebook.com/changetransformindia/ https://twitter.com/intothechange https://www.instagram.com/changetransformindia/ Listen to the Audio Podcast at: https://anchor.fm/transform-impossible https://podcasts.apple.com/us/podcast/change-i-m-possibleid1497201007?uo=4 https://open.spotify.com/show/56IZXdzH7M0OZUIZDb5mUZ https://www.breaker.audio/change-i-m-possible https://www.google.com/podcasts?feed=aHR0cHM6Ly9hbmNob3IuZm0vcy8xMjg4YzRmMC9wb2RjYXN0L3Jzcw Kindly Subscribe to CHANGE- I M POSSIBLE - youtube channel www.youtube.com/ctipodcast

The FAA is accountable for how aerospace impacts our planet. We join businesses, other governments, and citizens on a mission to "Invest In Our Planet," the theme for Earth Day 2022. We will continue to take bold actions, be innovative in our approaches, and implement solutions equitably. Just last year, U.S. Transportation Secretary Pete Buttigieg released the U.S. Aviation Climate Action Plan, which aims to achieve net-zero greenhouse gas emissions from U.S. aviation by 2050. Transportation produces the most emissions, and FAA is committed to doing its part to build a cleaner, quieter and more sustainable aviation system. In this special Earth Day episode of our podcast, we're talking to experts about sustainable fuels, new technologies, noise reduction and operational efficiency. You'll hear from Jim Hileman, the FAA's Chief Scientific and Technical Officer for the Environment; Greg McDougall, CEO, Harbour Air, Vancouver; and Dave Atwood, Structures and Propulsion Branch Manager, FAA William J. Hughes Technical Center. Operation Invest In Our Planet is underway. Tune in to learn how we're doing our part.

The FAA is accountable for how aerospace impacts our planet. We join businesses, other governments, and citizens on a mission to "Invest In Our Planet," the theme for Earth Day 2022. We will continue to take bold actions, be innovative in our approaches, and implement solutions equitably.Just last year, U.S. Transportation Secretary Pete Buttigieg released the U.S. Aviation Climate Action Plan, which aims to achieve net-zero greenhouse gas emissions from U.S. aviation by 2050. Transportation produces the most emissions, and FAA is committed to doing its part to build a cleaner, quieter and more sustainable aviation system.In this special Earth Day episode of our podcast, we're talking to experts about sustainable fuels, new technologies, noise reduction and operational efficiency. You'll hear from Jim Hileman, the FAA's Chief Scientific and Technical Officer for the Environment; Greg McDougall, CEO, Harbour Air, Vancouver; and Dave Atwood, Structures and Propulsion Branch Manager, FAA William J. Hughes Technical Center.Operation Invest In Our Planet is underway. Tune in to learn how we're doing our part.

Edward Neilan, MD, PhD, Chief Scientific and Medical Officer at the National Organization for Rare Disorders (NORD), discusses the organization's recently established Rare Disease Centers of Excellence.As Dr. Neilan explains, there were two main goals when establishing a national network of rare disease centers. The first goal was to help rare disease patients find medical centers that have deep and broad expertise and could assist them with their diagnosis or treatment of their disease. The second goal was to enable rare disease experts to work collaboratively, which will hopefully lead to faster progress in terms of diagnoses, treatments, and development of guidelines and new therapies. The application process for the NORD Rare Disease Centers of Excellence was extensive to ensure that each center, among other things, had extensive expertise. Some additional criteria for the selection of these centers included being actively involved in rare disease research, actively training the “next generation” of rare disease clinicians and researchers, and being able to provide care for all ages and assist with the transition for pediatric to adult care. NORD also evaluated if centers were providing education about rare diseases to the public and reaching out to underserved minorities.Dr. Neilan hopes that by establishing this network of centers, it will increase the sharing of information between physicians, which will in turn decrease the need for patients to travel across the country to receive proper care for their rare disease.

“For me, the beauty of diabetes was that it was the anchor but it allowed me to explore so many different areas of research and interest.” -Robert A. Gabbay, MD, PhD   In episode 158 of the podcast, we welcome Dr. Robert Gabbay. Dr. Gabbay is Chief Scientific and Medical Officer of the American Diabetes Association and Associate Professor at Harvard Medical School. DocWorking Founder and CEO, Dr. Jen Barna talks with Dr. Gabbay about how it all started for him, his journey in medicine, how he balances it all and what advice he was given and what advice he would give to his younger self. He speaks about difficult decisions he made that affected the direction of his career. Dr. Gabbay also talks about the importance that mentors have had in his life and how they helped to shape him.    Robert A. Gabbay, MD, PhD is Chief Scientific and Medical Officer of the American Diabetes Association and Associate Professor at Harvard Medical School. His research focuses on innovative models of diabetes care to improve diabetes outcomes and the lives of people with diabetes. Throughout his vibrant career he has had many accomplishments as a basic science researcher, developer of patient communication tools, creator of the first broad scale diabetes registry, designer of care management training programs, and leader of one of the largest primary care transformation efforts in the US around the Patient Centered Medical Home. The reach of his work has been recognized through leadership roles around the world to transform diabetes care including leading the International Diabetes Federation BRIDGES program that implements evidence based translational research to low resource global settings. Dr. Gabbay has received funding from the National Institute of Health Diabetes, Digestive and Kidneys Diseases (NIDDK), the Agency for Healthcare Research and Quality (AHRQ), and the Center for Medicare and Medicaid Innovation for his care transformation work. Along with an extensive peer reviewed publication record, his views have appeared in popular press such as the New York Times, CNN, the Washington Post, People, Oprah, and National Public Radio. Formerly, he held the role of Chief Medical Officer at Joslin Diabetes Center.   Find full transcripts of DocWorking: The Whole Physician Podcast episodes on the DocWorking Blog  DocWorking empowers physicians and entire health care teams to get on the path to achieving their dreams, both in and outside of work, with programs designed to help you maximize life with minimal time.   Are you a physician who would like to tell your story? Please email Amanda, our producer, at Amanda@docworking.com to be considered.   And if you like our podcast and would like to subscribe and leave us a 5 star review, we would be extremely grateful!   We're everywhere you like to get your podcasts! Apple iTunes, Spotify, iHeart Radio, Google, Pandora, Stitcher, PlayerFM, ListenNotes, Amazon, YouTube, Podbean   You can also find us on Instagram, Facebook, LinkedIn and Twitter.    Some links in our blogs and show notes are affiliate links, and purchases made via those links may result in payments to DocWorking. These help toward our production costs. Thank you for supporting DocWorking: The Whole Physician Podcast!   Occasionally, we discuss financial and legal topics. We are not financial or legal professionals. Please consult a licensed professional for financial or legal advice regarding your specific situation.   Podcast produced by: Amanda Taran

In the first episode of our new series, we're exploring how science advice, data and evidence are used by decision makers in government. Throughout today's episode, host Dr Rob Doubleday is joined by Sir Patrick Vallance, UK Government Chief Scientific Adviser, and Sheila Jasanoff, Pforzheimer Professor of Science and Technology Studies, Harvard Kennedy School. Season 5 is produced in partnership with the research project Expertise Under Pressure, Centre for the Humanities and Social Change at the University of Cambridge. -- CSaP: The Science & Policy Podcast is hosted by CSaP Executive Director Dr Rob Doubleday, and is edited and produced by CSaP Communications Coordinator Jessica Foster. Research for this series is also supported by CSaP Policy Researcher Nick Cosstick. Podcast theme music by Transistor.fm. Learn how to start a podcast here.

Society of Evidence Based Policing Chair and Met Commander Alex Murray speaks with Professor Paul Taylor, who earlier this year was appointed as the 1st National Policing Chief Scientific Advisor at the National Police Chiefs' Council   www.sebp.police.uk

Oxford Cannabinoid Technologies Holdings PLC (LSE:OCTP) Valentino Parravicini, Chief Scientific, Officer joins Proactive London's Katie Pilbeam to talk about their treatment for trigeminal neuralgia (TN). This is a rare and chronic pain condition which in most cases is excruciatingly painful and in the very worst cases patients even contemplate suicide. The aim is to secure orphan designation for the approach, which is conferred where there is an unmet medical need and the designation could shorten the timeline to market.

In celebration of Healthy Vision Month in May, the Focus on Diabetes™ initiative is launching The Next Step Eye Health Challenge to raise awareness of diabetes-related eye disease and the steps people can take to maintain better eye health. My guest is Dr. Robert Gabbay, the Chief Scientific and Medical Officer for the American Diabetes Association (ADA).

In celebration of Healthy Vision Month in May, the Focus on Diabetes™ initiative is launching The Next Step Eye Health Challenge to raise awareness of diabetes-related eye disease and the steps people can take to maintain better eye health. My guest is Dr. Robert Gabbay, the Chief Scientific and Medical Officer for the American Diabetes Association (ADA).

Hear Dr. Stacie Bell, Chief Scientific and Medical Officer at the NPF discuss palmoplantar psoriasis, dactylitis, enthesitis, plantar faciitis and more with podiatrist and foot and ankle surgeon Dr. Matthew Paden from Rocky Mountain Foot and Ankle Center in Wheat Ridge, CO. Disclosures/credit: https://www.eeds.com/em/2872. This program is supported by educational grants from Lilly, Bristol Myers Squibb, Novartis and Ortho Dermatologics. 

Hear Dr. Stacie Bell, Chief Scientific and Medical Officer at the NPF discuss palmoplantar psoriasis, dactylitis, enthesitis, plantar faciitis and more with podiatrist and foot and ankle surgeon Dr. Matthew Paden from Rocky Mountain Foot and Ankle Center in Wheat Ridge, CO. Disclosures/credit: https://www.eeds.com/em/2872. This program is supported by educational grants from Lilly, Bristol Myers Squibb, Novartis and Ortho Dermatologics. 

Curious about the research funded through the NPF? Hear about key research initiatives such as the PsA Diagnostic Test Grant and the Psoriasis Prevention Initiative along with the latest updates from Dr. Stacie Bell, Chief Scientific and Medical Officer, and Jackie Domire, Associate Director of Research and Medical Affairs. Psound Bytes is supported by unrestricted educational grants from Amgen, Bristol Myers Squibb, Pfizer and UCB. 

In this episode of Practice Pearls: Overcoming Therapeutic Inertia Drs. Robert Gabbay and Dr. Kamlesh Khunti discuss an overview of Therapeutic Inertia and the American Diabetes Associations initiative on overcoming therapeutic inertia. This is part of the American Diabetes Association’s Overcoming Therapeutic Inertia initiative supported by Strategic Sponsors AstraZeneca and Sanofi, plus Supporting Sponsors Merck and Novo Nordisk. This episode is sponsored by the Overcoming Therapeutic Inertia  Initiative - for more information about resources for overcoming therapeutic inertia, just go to www.TherapeuticInertia.diabetes.org .  Presented by: Robert Gabbay, MD, PhD, FACP, Chief Scientific and Medical Officer, American Diabetes Association Kamlesh Khunti, MD, PhD, Professor of Primary Care Diabetes & Vascular Medicine, University of Leicester, Leicester General Hospital, Leicester, UK Neil Skolnik, M.D. , Professor of Family and Community Medicine, Sidney Kimmel Medical College, Thomas Jefferson University, Associate Director, Family Medicine Residency Program, Abington Jefferson Health

Orly Levitan is the Chief Scientific of a cool startup called HyGIeacare Inc. While being in charge of the growing company's scientific program, she maintained her affiliation with Rutgers University. Post leaving her full-time research professor appointment with the university, she also co-created the curriculum and course work of the Project Management Consortium (PMC) of the Cheeky Scientist Association (CSA). In this episode, we talk about her transition to industry, keeping in touch with where you scientifically “came from”, and her love for teaching and mentoring. Hygieacare - https://hygieacare.com/for-physicians/publications/ CSA in general - https://cheekyscientist.com/, CSA Project Management (PMC) program - https://cheekyscientist.com/career-programs/project-management-consortium/ Photo credit - Tess Scheflan https://tess-scheflan.squarespace.com/ Music - Funkorama by Kevin MacLeod Link: https://incompetech.filmmusic.io/song/3788-funkorama License: http://creativecommons.org/licenses/by/4.0/ --- Send in a voice message: https://anchor.fm/macademia/message

What are the hidden deaths during the coronavirus pandemic, Face Mask Rage, and Chief Scientific officer Sir Patrick Vallance warns, we must learn to live with the virus.

Chrononutrition and sleep strategies with Greg potter Phd I had a fascinating talk with Greg and we go deep into the research behind nutrition and biological clocks, and all aspects of sleep. This is a very very informative podcast that will expand your mind!! It sure did mine! Greg has a BSc and an MSc in Exercise Physiology from Loughborough University, where he coached a sprinter to four gold medals at the European Championships. Greg has also worked with groups such as The United States Naval Special Warfare Command on health and performance optimization. He is now Chief Scientific officer for a digital health startup. Greg Potter's PhD work at the University of Leeds on sleep, diet, and metabolic health was featured by the likes of the BBC World Service, the Washington Post, and Reuters. We discuss: What is chrononutrition Fasting/ ideal eating times Eating windows and ideal time for greatest energy consumption. Differences in males and females Biological clocks- circadian rhythms, light dark cycle, peripheral clocks, eating and fasting. Chronotypes and sleep Why sleep is imperative to health and disease prevention. How much sleep we actually need? Dietary support strategies for good sleep Sleep across the lifespan Tracking sleep and validity Caffeine implications Hydration implications Waking up 2/3am What improves REM and Non REM Why we can't sleep - impacts of light and environment  How to improve sleep Sleeping aids and supplements- Resilient Nutrition Plus lots lots more in between!!!   Find Greg here: @resilientnuts @gregpotterphd https://resilientnutrition.com

On September 20, 2020, our host Dr. Marianne Ritchie was joined by Dr. Robert Gabbay and Dr. Jeffrey Joseph​ for a discussion on diabetes. Dr. Gabbay, is the Chief Scientific and Medical Officer for the American Diabetes Association (ADA), the global authority on diabetes. He is also an Associate Professor of Medicine at Harvard Medical School. Dr. Joseph is a Professor of Anesthesiology, the Vice-Chairman & Director of Research for the Department of Anesthesiology, and Director of the Jefferson Artificial Pancreas Center at Thomas Jefferson University Hospital.Each week we highlight the #RealChampions in your life! Your family, friends, or colleagues who go the extra mile to help others in their community. For this week, Your Real Champion was Mae Krier! Hear the inspirational story of one of the millions of “Rosies” who helped America in the war against Hitler. Mae helped to establish the annual “Rosie the Riveter” Day and earned the Congressional Medal of Honor for “Rosie”.

Srinivas Rao is the Chief Scientific Officer at ATAI Life Sciences AG. Dr. has over 19 years of professional experience in the pharmaceutical and biotechnology industries. Prior to ATAI, Dr. Rao has held the titles of Chief Scientific, Medical, or Executive Officer at companies ranging from venture backed startups to vertically-integrated, publicly traded pharmaceutical companies. Dr. Rao completed an internship in Internal Medicine at Yale-New Haven Hospital. He received his Ph.D. in neurobiology from Yale Graduate School and his M.D. from Yale School of Medicine. He holds both a Bachelor of Science and Master of Science degree in Electrical Engineering from Yale College and Yale Graduate School, respectively.

Our first conversation is one of the most downloaded episodes of the podcast! Greg Potter PhD returns for a discussion about the effects of COVID-19 on sleep, what to do about stress induced insomnia, formulas for behavior change leading to better sleep, and Resilient Nutrition.Who is Greg Potter, PhD? Greg Potter’s PhD work at the University of Leeds on sleep, diet, and metabolic health was featured by the likes of the BBC World Service, the Washington Post, and Reuters. Greg has a BSc and an MSc in Exercise Physiology from Loughborough University, where he coached a sprinter to four gold medals at the European Championships. Greg has also worked with groups such as The United States Naval Special Warfare Command on health and performance optimization. He is now Chief Scientific officer for a digital health startup.Highlights[5:23] COVID-19 and Sleep Disturbance [10:14] Tracking Data for Health and Sleep Optimization[18:46] What metrics matter[28:40] Beating Anxiety induced Insomnia[39:03] Optimizing the Sleep-Wake Cycle[45:48] Creating a sleep routine[52:30] Sleep Supportive Nutrients and Supplements[1:02:10] Resilient NutritionResourcesChrononutrition: Optimal Meal Timing for Epic Energy, Focus and Body Composition with Greg PotterSleepio AppTobias Lundgren Bull’s Eye ExerciseVO2 max Cooper TestRestwelle MelatoninPittsburgh Sleep Quality IndexSponsorsResilient NutritionI met Greg Potter at a speaking event in Latvia. 9 months later, I met Ali Macdonald at a speaking event in London. Ali and Greg mentioned they were working on something special in the endurance space. And damn... they have done a fantastic job of tackling endurance nutrition. I remember when I was going back to run the Brussels marathon and I was looking at the options for fueling during the race. I was surprised by the lack of real food, but also things that supported me during my run.Enter Resilient Nutrition.Ali and Greg have developed a formula which is called Long Range Fuel, and there are several choices for you, which now I use for everything from cognitive endurance to my physical endurance. Head on over to resilientnutrition.com and get yours today because they taste so fricking good. Use the code Boomer for 10% off. VielightVielight combines science and engineering ingenuity to develop unique devices that deliver photons to the brain and inner systems. Their mission is to create photobiomodulation devices that are safe and effective – to help improve one’s quality of life.The Neuro Alpha is a staple in my stress resilience and sleep improvement routine. I get better sleep, better focus, and less anxiety around public speaking. And… increased ability to drop into flow.Go to vielight.com and use the promo code BOOMER for 10% off your purchase.Continue Your High Performance Journey with Greg Potter PhDResilient NutritionResilient Nutrition FacebookResearch GateLinkedInInstagramTwitterDisclaimer This information is being provided to you for educational and informational purposes only. This is being provided as a self-help tool to help you understand your genetics, biodata and other information to enhance your performance. It is not medical or psychological advice. Virtuosity LLC, or Decoding Superhuman, is not a doctor. Virtuosity LLC is not treating, preventing, healing, or diagnosing disease. This information is to be used at your own risk based on your own judgment. For the full Disclaimer, please go to (Decodingsuperhuman.com/disclaimer). See acast.com/privacy for privacy and opt-out information.

In the second episode of a three-part series dedicated to highlighting rare disease, Conference Forum reporter Danny McCarthy sits down with C Frank Bennett, PhD, of Ionis Pharmaceuticals, to discuss Spinal Muscular Atrophy. Dr Bennett is Executive Vice President and Chief Scientific Officer at Ionis Pharmaceuticals, and one of the founding members of the company. He is responsible for continuing to advance antisense technology and expanding Ionis drug discovery platform. Dr. Bennet is a co-recipient of the 2019 Breakthrough Prize in Life Sciences for his contributions to the discovery and development of SPINRAZA® (nusinersen).  Spinal muscular atrophy is a genetic, degenerative neuromuscular disorder characterized by weakness and wasting in muscles used for movement. It is caused by a loss of specialized nerve cells, called motor neurons that control muscle movement.  Dr Bennett includes two sources of information about Ionis and SMA: Ionispharma.com and Spinraza.com.

Through this special episode learn what the Coronavirus means for you and your psoriasis and/or psoriatic arthritis. Hear answers to your questions from dermatologist, Dr. Mark Lebwohl , the Waldman Professor and Chairman of the Kimberly and Eric J. Waldman Department of Dermatology, Icahn School of Medicine at Mt. Sinai Health System in New York, and Dr. Stacie Bell, Chief Scientific and Medical Officer at the National Psoriasis Foundation.  

Greg Potter, PhD discusses the biological clock, best times to eat and fast, and what you really need to do to discover whether you are a day person or a night person.Who is Greg Potter, PhD?Greg Potter's PhD work at the University of Leeds on sleep, diet, and metabolic health was featured by the likes of the BBC World Service, the Washington Post, and Reuters. Greg has a BSc and an MSc in Exercise Physiology from Loughborough University, where he coached a sprinter to four gold medals at the European Championships. Greg has also worked with groups such as The United States Naval Special Warfare Command on health and performance optimization. He is now Chief Scientific officer for a digital health startup.Highlights[3:20] The issue with quoting percentages of night and morning people[8:00] Biological clocks- circadian rhythms, light dark cycle, peripheral clocks, eating and fasting[13:54] Biological daytime and how can we hack it[18:46] Age and biological clock[20:25] What is chrononutrition?[22:28] Time restricted feeding - morning fasting versus early time restricted feeding[28:15] Enhancing morning focus and cognition[32:24] When to eat and meal sizes[44:40] One meal a day - is it sustainable?[51:50] Biological clock and recovery from jet lag[59:40] Greg answers the final four questionsResourcesDigital Minimalism by Cal NewportDoing Good Better by William MacAskillHealth Optimisation Summit TicketsBiohacker Summit - FinlandSponsorWhat brands of blue light blockers do we recommend? BLUBlox is definitely the go to. The CEO Andy Mant on the show before where we got into a really deep dive on blue light. If you get any amount of blue light in your glasses, no matter if it’s 3%, 10%, it disrupts melatonin production. So Andy has created blue light blockers that hold up to the highest standards. And in fact, you can see he’s tested it versus other brands and that they always come out on top. Quality matters. If you head over to blublox.com and plug in the code “DS15”, you’re going to get 15% off your order.DisclaimerThis information is being provided to you for educational and informational purposes only. This is being provided as a self-help tool to help you understand your genetics, biodata and other information to enhance your performance. It is not medical or psychological advice. Virtuosity LLC, or Decoding Superhuman, is not a doctor. Virtuosity LLC is not treating, preventing, healing, or diagnosing disease. This information is to be used at your own risk based on your own judgment. For the full Disclaimer, please go to (Decodingsuperhuman.com/disclaimer). See acast.com/privacy for privacy and opt-out information.

Dr. Barrett Rollins, the chief scientific medical officer at Dana-Farber, joins the Greg Hill Show speaks to the importance of basic cancer research and its role in the development of clinical advances.  Dr. Rollins also describes managing the scientific, technologic, and research operations of the Dana-Farber institute.

Pennsylvanias premier medical marijuana therapeutics, Ilera Healthcare, company and the main medical cannabis supplier for the entire state, will soon introduce a series of groundbreaking medicines whose formulation is based upon current scientific and clinical research on the effects of cannabis on chronic ailments. Ilera’s latest offering using this technique is HOPE™, which will be available in early May.  Ilera’s research and development team lead by Chief Scientific officer/EVP Dr. Oludare Odumosu.

SPECIAL EPISODE! [We strongly recommend listening to Base Pairs episode 17 to contextualize this extended discussion.] Some of the most sought after gifts this holiday season are at-home DNA tests. These tests let anyone send a sample of his or her DNA to get analyzed for various results: the geographic location of ancestors; predisposition to illness; and other data points a person’s genetic code can reveal about themselves. But there is more to personal genotyping than simply learning about ourselves. Host Brian Stallard sat down with Dr. Yaniv Erlich, a Watson School of Biological Sciences alumnus who is currently the Chief Scientific officer at MyHeritage DNA, to get his unique academic and commercial perspective on the use of personal genetic information. Listen as Erlich discusses privacy concerns, using genetics for justice, and his list of pros and cons for finding out about your genetic code.

Dr. Fischer is back! On his second trip to the show, Dr. Fischer reveals the inspiration behind “Discovery with Purpose”. How can life science innovate like tech? How is IBRI helping to combat midwestern “brain drain”? Why is it so important to focus on curing disease in addition to just finding the next treatment? Does the band U2 really hang out in Joshua Tree National Park? Rainer Fischer, PhD Chief Executive Officer, Chief Scientific and Innovation Officer Rainer Fischer, PhD, joined the IBRI in April of 2017 as the Chief Scientific and Innovation Officer. In October that same year, he also was named Chief Executive Officer. Fischer spent 19 years building and leading the Fraunhofer Institute for Molecular Biology and Applied Ecology (IME) in Aachen, Schmallenberg, Muenster, Giessen, Frankfurt and Hamburg in Germany, and its subsidiaries in Newark, Delaware, USA and Santiago, Chile. The Fraunhofer-Gesellschaft is the largest applied science research organization in Europe, with applied research aimed at addressing issues of health, security, production technology, energy, materials, and the environment. During his time at the Fraunhofer-Gesellschaft, Fischer grew the IME Institute from 40 to 680 employees, raised with his team almost one billion euro in extramural research funding, and established international collaborations with academia and industry in more than 25 countries. Those collaborations include many of the leading global companies in the biotechnology, pharmaceuticals, agriculture, food and chemical industries. Fischer also served as Department Head of the Institute for Molecular Biotechnology at RWTH Aachen University where he was awarded a Distinguished Professorship in 2015. He created the department, co-establishing both undergraduate and graduate programs that have matriculated more than 500 students including 115 graduated PhD students. Fischer is a prolific presenter and has published more than 340 peer reviewed scientific papers that have been cited over 16,000 times.  In addition to his academic and leadership experience, he co-founded five biotechnology startups, holds over 60 issued patents and has more than 120 patent applications pending. Fischer also holds a second Professorship at Maastricht University, Netherlands where he co-founded the Aachen-Maastricht-Institute-of-Biobased-Materials (AMIBM) in 2015.

This week Inside INdiana Business Host Gerry Dick is joined by Rainer Fischer, CEO and Chief Scientific and Innovation Officer, Indiana Bioscience Research Institute

Dr. Rollins manages the scientific and research operations of Dana-Farber. Dr. Rollins can speak about the importance of basic cancer research and its impact on patient care.

Dr. Rollins manages the scientific, technological and research operations of Dana-Farber. Dr. Rollins can speak about the importance of basic cancer research and its role in developing clinical advances.

Brian Kursonis is our first guest on the Lets Just Talk show, he will discuss his personal story about Alzheimer’s and offers others resources to navigate an early-onset Alzheimer’s. Dr. William T. Cefalu is Chief Scientific, Medical & Mission Officer at the American Diabetes Association (Association),This show is broadcast live on Thursday's 2PM ET on W4CY Radio – (www.w4cy.com) part of Talk 4 Radio (http://www.talk4radio.com/) on the Talk 4 Media Network (http://www.talk4media.com/

ControlTalk NOW — Smart Buildings VideoCast|PodCast for Week Ending Sep 25, 2016 features Intelligent Buildings’ Director of Cyber Security, Fred Gordy, who details the exposure and vulnerability of Operational Technology, which run our buildings. Watch as Fred reviews, step by step — the hacker’s modus operandi. Sameer Pradhan, Director of ControlTrends India, updates the ControlTrends Community on India’s colossal Smart City imitative; Schneider Electric releases their new MG350 Smart Actuators with alarming features; Contemporary Controls’ newest network solution offers greater speed and diagnostics; Larry Andriunas takes the helm at Kodaro, LLC; and this week’s ControlTalk Rewind takes us back to the future with Ecorithm’s Dr. Igor Mezic and artificial intelligence. CTN 199 Controltalk Now -The Smart Buildings Video Cast from Eric Stromquist on Vimeo. MG350 SmartX Actuator offers great havoc control Schneider Electric Has a Hit with The New MG350 SmartX Actuators. Awesome video and cool new actuator series from Schneider Electric. The SmartX MG 350 is the first NEW SmartX Actuator released globally. It is designed to control two and three-way globe valves in a wide range of applications. The MG350 SmartX Actuator is the platform for the future, acting as the foundation of both a SmartStruxure solution and SmartStruxure Lite solution. The critical information delivered by the actuator helps the BMS operate at optimal efficiency. ControlTalk NOW’s first interview is with Fred Gordy, Intelligent Building’s Director of Cyber Security. As our industry’s leading cyber security expert, Fred focuses on the specific vulnerabilities concerning Operational Technology, controllers on building networks that control the HVAC equipment and building systems and equipment versus Information Technology. Operational Technologies were designed for availability and comfort, which was suitable at the time, but when the need to share information across subnets made Broadcast BACnet Management Devices necessary, as well as using a public IP address, the security imperative was not factored into the equation. Watch this video! and, visit the NIST Cyber Security Framework website for basic recommendations to protect your Operational Technology. Larry Andriunas Larry Andriunas announces the launch of Kodaro, LLC, a software development company which he will lead from California’s Bay Area. Operating in the building automation industry, Kodaro is hard at work creating ways to connect building controls through software drivers, software applications, and enterprise solutions. “I’m very excited about launching Kodaro,” said Andriunas, a 28-year building controls expert. “The building automation industry is at an interesting time where new technologies are finally converging. Kodaro will lead the way for innovation in support of contractors and integrators.” ControlTalk NOW’s second interview is with Director, ControlTrends India, Sameer Pradhan. Sameer Pradhan is also the Managing Director of CICC Automation Technologies, a leading international building automation systems provider. Sameer recently chaired a panel discussion on Smart Connected Intelligent Buildings — The Foundation for Smart Cities,” that discussed in great detail, the critical aspects of the smart city standard and its core component, the intelligent building. India has presently identified 60 cities that will be included in this massive initiative. Great update! Contemporary Controls: The Need for Speed and Diagnostics. Contemporary Controls is introducing the unmanaged EISK8-GT/H 8 port gigabit Ethernet switch with hub functionality. Yes, we purposely “broke” the address learning functionality of the switch so that all messages – directed, multicast, broadcast – are flooded to all ports on the switch allowing a protocol analyzer tool such as Wireshark® the ability to observe all traffic on the network. How Using Artificial Intelligence in Smart Buildings will make them smarter ControlTalk Rewind: Using Artificial Intelligence to Make Smart Buildings Smarter. Last Spring Ken and I had the opportunity to interview a couple of very interesting characters, who put a new spin on how to make smart buildings smarter through the use of artificial intelligence. This is next-gen analytics! Dr. Igor Mezic, Ecorithm’s Chief Scientific and Technology Advisor & Co-Founder, and John Morris, VP Marketing and Sales. Ecorithm is able to provide faster and more accurate results that other analytics companies, and why Ecorithm’s SaaS is necessary for the entire lifetime of the system. The post Episode 199 ControlTalk NOW — Smart Buildings VideoCast|PodCast for Week Ending Sep 25, 2016 appeared first on ControlTrends.

ControlTalk NOW — Smart Buildings VideoCast and Podcast for week ending April 17, 2016 takes a good look at the technology driving Honeywell’s second generation Lyric thermostat — featuring geofencing that triggers a mobile device application when the device enters or exits the specified area, and Ecorithm’s use of Artificial Intelligence in Smart Buildings. Functional Devices asks why pay for more? Don’t miss the the latest Pub Talk with Mike Marston and the Easy IO partners from Australia, and of special note: Make your plans NOW to attend the RealComm/IBcon 2016 coming to San Jose June 21-24! 30 Minutes with Lynxspring Webinar Series: Lynxspring’s New E2E Cellular Data Service and Onyxx CE121 Cellular Router. The next “30 Minutes with Lynxspring,” our monthly webinar series featuring Lynxspring subject-matter experts and special guests, is scheduled for Wednesday, April 20th at 12:00 PM CDT. April’s Webinar looks at Lynxspring’s new E2E Cellular Data Service, a high-security, private cellular data network, and the new Onyxx CE121 Cellular Router. Register here! Watch Out Nest: The Second Generation Lyric is Making Beautiful Music. Many think that Nest owns the “cool factor” when it comes to residential thermostats. Not so fast, the orginators of the round thermostat are coming on strong with their second generation Lyric thermostat. That’s right, Honeywell, the company that, as far as we know, has built more thermostats than any other company on the planet, and advanced thermostat technology since 1885, is showing that in addition to unsurpassed technology and engineering, they know a think to two about style. Don’t settle for another pretty face. With Honeywell you get style and substance. Check out the Smart, Connected, High Performance Intelligent Buildings Conference. Where else can you learn about the latest trends in Smart Buildings and rub elbows with potential customers? RealComm/IBcon 2016 offers this unique opportunity, and is the place to be June 21-24. Click here to register. Act Now Early bird discount ends April 15th. IBcon has grown to become the world’s most comprehensive and leading edge discussion on the next generation of smart, connected, high-performance, green, sustainable, intelligent buildings. This event is not about the traditional one building, one system, one vendor smart building of yesterday, but rather the open architected, interoperable, integrated, IP, IT centric smart buildings of tomorrow. Register here! Functional Devices Asks: Why Pay More Than You Need? Functional Devices, Inc. has been designing and manufacturing quality electronic devices in the United States of America since 1969. Our goal is to provide high quality products for the most reliable and economical solutions to the needs of our customers, along with world-class support from our sales and engineering experts. Current product offerings include relays, current sensors, power control, enclosures, power supplies, transformers, and accessories. Ecorithm’s Dr. Igor Mezic and John Morris Explain True Analytics and Using Artificial Intelligence in Smart Buildings. This is next-gen analytics! Dr. Igor Mezic, Ecorithm’s Chief Scientific and Technology Advisor & Co-Founder, and John Morris, VP Marketing and Sales, tell ControlTrends about what inspired Igor to develop Ecorithm’s technology, why Ecorithm is able to provide faster and more accurate results that other analytics companies, and why Ecorithm’s SaaS is necessary for the entire lifetime of the system. The post ControlTalk NOW — Smart Buildings VideoCast and Podcast for Week Ending April 17, 2016 appeared first on ControlTrends.

ControlTalk NOW — Smart Buildings VideoCast and Podcast for week ending February 7, 2016 features interviews with Dr. Igor Mezic and John Norris of Ecorithm and Ken Sinclair, owner and editor of Automated Buildings, and Neptronic’s VP of Sales and Marketing, Luis Melgares, along with Andy McMillan’s presentation at the Connected Community Collaboration, a product update from Vykon. Of special note was the announcement of Sameer Pradhan as Director of ControlTrends India. CTN 166- The Smart Buildings Video Cast- from Eric Stromquist on Vimeo. ControlTalk NOW interview with Dr. Igor Mezic, Chief Scientific and Technical Advisor​, Co-Founder​ and John Morris, VP of Sales and Marketing of Ecorithm, a firm from Santa Barbara that is reshaping what it means to benchmark, showcase, and ensure occupant comfort, operational efficiency, and building health. Dr. Mezic is a world-renowned expert in the field of building energy efficiency. He is a Professor of Mechanical Engineering at University of California, Santa Barbara (UCSB). His major scientific contribution has been the development of operator-theoretic methods for analysis of complex dynamical systems, that led to a massive number of applications in “Big Data Dynamics” – a term he coined. Ken Sinclair’s Automated Buildings February, 2016 Release: “Making it Mashable.” Ken Sinclair, owner and editor of Automated Buildings, applies the word mashable to the building automation world. Mashable, which the Urban Dictionary defines as “a term used to describe two or more online applications that work together and/or within each other.” February’s AB theme, “Making it Mashable,” addresses then, a very relevant concern — that as we sort through the maelstrom of exponential IoT technology impacting our industry, an industry that seeks optimality in every aspect of smart building control, data integration, and the maximum realization of energy and operational efficiencies — the question becomes, are we there yet? The technology certainly is, but our “mashability,” will ultimately answer yes or no for us. VYKON Integrated Analytics Available Now on JACE Hardware. Latest version 1.1 includes advanced data visualization module! VYKON Integrated Analytics broke new ground when it was introduced. This innovative product uses real-time analytics at the edge (device level) to harness the enormous power of the Internet of Things. Today, Niagara users are even better positioned to capitalize on the IoT data explosion. Niagara AX Supervisors and select JACE® controllers now feature the latest version of VYKON Integrated Analytics with advanced data visualization. Luis Melgares Details Neptronic’s New Multi-App Controller at 2016 AHR EXPO. Luis Melgares, VP of Sales and Marketing, updates the ControlTrends Community on Neptronic’s versatile Multi-App controller, able to provide stand-alone or networked control for all packaged AC RTUs, Heat Pump, Fan Coil Unit, and heating and cooling equipment applications, using a configuration set up with a greatly improved menu structure. No programming is required! Neptronic now manufactures the industry’s first Smart Duct Heater, which is networkable via BACnet and Modbus — a game-changing addition to their industry-leading portfolio of ball valves, actuators, and humidifiers. 2015 ControlTrends Awards Highlight: The Thermostat of the Year. Congratulations to Siemens. Their RDY 2000 Thermostat was voted the best commercial thermostat of the year by the global ControlTrends Community. The RDY 2000 can control conventional systems with up to three stages of heating and three stages of cooling, as well as heat pumps with up to two compressors and up to two stages of auxiliary heat. The RDY2000 also features outputs that control humidification/dehumidification equipment, maintain indoor air quality with optional CO2 sensor, and maximize energy savings with interface to economizer controls. Click here to see what makes the Siemens RDY 2000 so special. Andy McMillan, president BACnet International (recently returned from China) opened the collaboratory discussions with an insight into how global transformation impacts all walks of life and summoned building automation professionals to be open, connected, collaborative, and receptive to transformation. As president of BACnet International, Andy works with users and suppliers to expand and enhance the BACnet community. ControlTrends Introduces Sameer Pradhan, Director of ControlTrends India. ControlTrends was excited to announce that ControlTrends India has been formed and was absolutely delighted to introduce Sameer Pradhan as Director of ControlTrends India. The announcement took place at the 2015 ControlTrends Awards held the evening before the start of the AHR Expo 2016, in Orlando Florida. The global ControlTrends Community, particularly those located in the India and Southeast Asia regions, will be greatly enriched by Sameer’s visionary leadership and executive capabilities. ControlTrends India’s website www.controltrends.in is now fully operational. The post ControlTalk NOW — Smart Buildings VideoCast and Podcast for Week Ending February 7, 2016 appeared first on ControlTrends.

For those of you who have been living under a rock, there has been some REALLY exciting progress over the last few years in the area of DS research.  Who better to tell us about it than the Chief Scientific … Continue reading →

Global warming, renewable energy, infectious diseases, science education. Scientific American, founded in 1845, is the foremost publication for individuals who want to understand the science and technology that is shaping our world. John Rennie is only the seventh editor in chief in the 160-year history of SCIENTIFIC AMERICAN magazine. In 2000 the Council of Scientific Society Presidents bestowed on Mr. Rennie its Sagan Award for Public Understanding of Science, which is given annually 'to honor those who have become concurrently accomplished as researchers and-or educators, and as widely recognized magnifiers of the public's understanding of science'.

Global warming, renewable energy, infectious diseases, science education. Scientific American, founded in 1845, is the foremost publication for individuals who want to understand the science and technology that is shaping our world. John Rennie is only the seventh editor in chief in the 160-year history of SCIENTIFIC AMERICAN magazine. In 2000 the Council of Scientific Society Presidents bestowed on Mr. Rennie its Sagan Award for Public Understanding of Science, which is given annually 'to honor those who have become concurrently accomplished as researchers and-or educators, and as widely recognized magnifiers of the public's understanding of science'.